Obesity Surgery

, Volume 21, Issue 5, pp 616–624 | Cite as

Weight Loss and Changes in Salivary Ghrelin and Adiponectin: Comparison Between Sleeve Gastrectomy and Roux-en-Y Gastric Bypass and Gastric Banding

  • Frank Benedix
  • Sabine Westphal
  • Robert Patschke
  • Dennis Granowski
  • Claus Luley
  • Hans Lippert
  • Stephanie Wolff
Clinical Research



Weight loss is associated with increased levels of adiponectin with a greater increase observed following Roux-en-Y gastric bypass (RYGB) compared to restrictive procedures. However, currently there are no data on changes in adiponectin following laparoscopic sleeve gastrectomy (LSG). Ghrelin was reported to be also produced by the salivary glands. There are also no data available regarding its changes following bariatric surgery.


The present study examined weight loss, and salivary ghrelin and HMW adiponectin levels in 43 morbidly obese subjects undergoing three different types of bariatric surgery.


We found that weight loss following LSG is superior to laparoscopic adjustable gastric banding (LAGB) and comparable to RYGB at 12 months after surgery. Although blood glucose decreased similarly following all three procedures, fasting insulin continuously declined only in LSG and RYGB patients. Changes in both fasting and postprandial salivary ghrelin greatly varied between all three procedures with no similarities to changes in serum ghrelin reported in the literature. HMW adiponectin significantly increased following LSG, and this increase was more marked than in LAGB patients and almost identical compared to RYGB.


Weight loss following LSG is comparable to RYGB in the short term. Changes in HMW adiponectin are comparable following LSG and RYGB which may further contribute to the successful results after LSG. Furthermore, the results of the present study support the hypothesis that there is an autonomous production of ghrelin in salivary glands irrespective of nutritional status and weight loss.


Salivary ghrelin Adiponectin Sleeve gastrectomy Obesity 



We thank Ruma Makarowa, Institute of Clinical Chemistry and Pathobiochemistry, University Magdeburg, for her support in the laboratory.

Conflict of interest disclosure

The authors declare that they have no conflict of interest.


  1. 1.
    Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.PubMedCrossRefGoogle Scholar
  2. 2.
    Moy J, Pomp A, Dakin G, et al. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg. 2008;196:e56–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Hüttl TP, Obeidat FW, Parhofer KG, et al. Operative techniques and outcomes in metabolic surgery: sleeve gastrectomy. Zentralbl Chir. 2009;134:24–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Aydin S, Halifeoglu I, Ozercan IH, et al. A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Peptides. 2005;26:647–52.PubMedCrossRefGoogle Scholar
  5. 5.
    Gröschl M, Topf HG, Bohlender J, et al. Identification of ghrelin in human saliva: production by the salivary glands and potential role in proliferation of oral keratinocytes. Clin Chem. 2005;51:997–1006.PubMedCrossRefGoogle Scholar
  6. 6.
    Aydin S, Aydin S, Ozkan Y, et al. Ghrelin is present in human colostrum, transitional and mature milk. Peptides. 2006;27:878–82.PubMedCrossRefGoogle Scholar
  7. 7.
    Yoshimoto A, Mori K, Sugawara A, et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol. 2002;13:2748–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908–13.PubMedCrossRefGoogle Scholar
  9. 9.
    Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.PubMedCrossRefGoogle Scholar
  10. 10.
    English PJ, Ghatei MA, Malik IA, et al. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab. 2002;87:2984.PubMedCrossRefGoogle Scholar
  11. 11.
    Benedix F, Westphal S, Patschke R et al. Comparison of serum and salivary ghrelin in healthy adults, morbidly obese, and patients with metastatic carcinoma. Obes Surg 2010 [Epub ahead of print]Google Scholar
  12. 12.
    Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Butner KL, Nickols-Richardson SM, Clark SF, et al. A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg. 2010;20:559–68.PubMedCrossRefGoogle Scholar
  14. 14.
    Swarbrick MM, Austrheim-Smith IT, Stanhope KL, et al. Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery. Diabetologia. 2006;49:2552–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Geloneze B, Pereira JA, Pareja JC, et al. Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass. Arq Bras Endocrinol Metabol. 2009;53:293–300.PubMedGoogle Scholar
  16. 16.
    Trakhtenbroit MA, Leichman JG, Algahim MF, et al. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med. 2009;122:435–42.PubMedCrossRefGoogle Scholar
  17. 17.
    Shi X, Karmali S, Sharma AM, et al. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2010;20:1171–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20:535–40.PubMedCrossRefGoogle Scholar
  19. 19.
    Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.PubMedCrossRefGoogle Scholar
  20. 20.
    Strain GW, Gagner M, Pomp A, et al. Comparison of weight loss and body composition changes with four surgical procedures. Surg Obes Relat Dis. 2009;5:582–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Sabbagh C, Verhaeghe P, Dhahri A, et al. Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding. Obes Surg. 2010;20:679–84.PubMedCrossRefGoogle Scholar
  22. 22.
    Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Lakdawala MA, Bhasker A, Mulchandani D, et al. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg. 2010;20:1–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Wang Y, Liu J. Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes Surg. 2009;19:357–62.PubMedCrossRefGoogle Scholar
  27. 27.
    Peterli R, Wölnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg. 2009;250:234–41.PubMedCrossRefGoogle Scholar
  28. 28.
    Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity. 2006;14:1553–61.PubMedCrossRefGoogle Scholar
  29. 29.
    Holdstock C, Engström BE, Ohrvall M, et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88:3177–83.PubMedCrossRefGoogle Scholar
  30. 30.
    Cetinkaya Z, Aydin S, Cerrahoglu YZ, et al. Changes in appetite hormone (ghrelin) levels of saliva and serum in acute appendicitis cases before and after operation. Appetite. 2009;52:104–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Guerre-Millo M. Adiponectin: an update. Diab Metab. 2008;34:12–8.Google Scholar
  32. 32.
    Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 2005;15:692–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.PubMedCrossRefGoogle Scholar
  34. 34.
    Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg. 2006;16:554–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.PubMedCrossRefGoogle Scholar
  36. 36.
    DePaula AL, Macedo AL, Schraibman V, et al. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20–34. Surg Endosc. 2009;23:1724–32.PubMedCrossRefGoogle Scholar
  37. 37.
    Xu A, Chan KW, Hoo RL, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280:18073–80.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2011

Authors and Affiliations

  • Frank Benedix
    • 1
  • Sabine Westphal
    • 2
  • Robert Patschke
    • 1
  • Dennis Granowski
    • 1
  • Claus Luley
    • 2
  • Hans Lippert
    • 1
  • Stephanie Wolff
    • 1
  1. 1.Department of General, Visceral and Vascular SurgeryOtto-von-Guericke University MagdeburgMagdeburgGermany
  2. 2.Institute of Clinical Chemistry and PathobiochemistryOtto-von-Guericke University MagdeburgMagdeburgGermany

Personalised recommendations